Study of Clinic-based Versus Self-use of Medical Abortion Pills

NCT03727308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4196

Last updated 2021-09-05

No results posted yet for this study

Summary

The goal of the study is to determine whether important clinical outcomes differ among women who access a combined medical abortion regimen from a pharmacy when compared with those who access it from a facility.

Conditions

  • Induced Abortion
  • First Trimester Abortion
  • Misoprostol
  • Mifepristone

Interventions

BEHAVIORAL

Medical abortion pills sourced from pharmacies

One cohort using medical abortion pills sourced from pharmacies

BEHAVIORAL

Medical abortion pills sourced from health clinics

One cohort using medical abortion pills sourced from health clinics

Sponsors & Collaborators

  • University of Health Science, Phnom Penh, Cambodia

    collaborator UNKNOWN
  • Ipas

    lead OTHER

Principal Investigators

  • Nathalie Kapp, MD, MPH · Ipas

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-30
Primary Completion
2021-06-02
Completion
2021-06-02

Countries

  • Cambodia
  • Ghana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727308 on ClinicalTrials.gov